tiprankstipranks
Trending News
More News >
Xspray Pharma AB (DE:6XP)
FRANKFURT:6XP
Germany Market

Xspray Pharma AB (6XP) Financial Statements

Compare
2 Followers

Xspray Pharma AB Financial Overview

Xspray Pharma AB's market cap is currently €102.48M. The company's EPS TTM is €-0.083019086; its P/E ratio is -5.90; Xspray Pharma AB is scheduled to report earnings on February 12, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr -5.58Mkr -8.55Mkr -9.19Mkr -9.53Mkr -8.87M
Operating Incomekr -161.85Mkr -283.24Mkr -181.73Mkr -133.07Mkr -97.95M
EBITDAkr -156.27Mkr -277.76Mkr -169.81Mkr -122.13Mkr -87.82M
Net Incomekr -171.44Mkr -285.52Mkr -179.67Mkr -130.27Mkr -96.70M
Balance Sheet
Cash & Short-Term Investmentskr 153.75Mkr 208.24Mkr 166.30Mkr 120.17Mkr 271.88M
Total Assetskr 769.35Mkr 796.34Mkr 765.26Mkr 585.43Mkr 622.90M
Total Debtkr 170.11Mkr 128.22Mkr 36.81Mkr 2.13Mkr 3.23M
Net Debtkr 16.36Mkr -80.02Mkr -129.50Mkr -118.04Mkr -268.65M
Total Liabilitieskr 164.70Mkr 173.25Mkr 71.85Mkr 29.41Mkr 31.15M
Stockholders' Equitykr 604.65Mkr 623.10Mkr 693.41Mkr 556.02Mkr 591.75M
Cash Flow
Free Cash Flowkr -193.16Mkr -264.51Mkr -257.38Mkr -238.47Mkr -147.57M
Operating Cash Flowkr -193.16Mkr -222.37Mkr -203.28Mkr -110.18Mkr -51.61M
Investing Cash Flowkr -29.19Mkr -42.14Mkr -65.88Mkr -135.34Mkr -105.82M
Financing Cash Flowkr 168.29Mkr 306.11Mkr 315.59Mkr 93.81Mkr 103.71M
Currency in SEK

Xspray Pharma AB Earnings and Revenue History

Xspray Pharma AB Debt to Assets

Xspray Pharma AB Cash Flow

Xspray Pharma AB Forecast EPS vs Actual EPS